Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28379552 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL17660486 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL431419 | 0.88 | LMNA (0.35) | LMNA | |
| SCHEMBL20202338 | 0.85 | LMNA (0.33) | LMNA | |
| SCHEMBL20202342 | 0.83 | LMNA (0.34) | LMNA | |
| SCHEMBL1013341 | 0.82 | LMNA (0.39) | LMNA | |
| SCHEMBL25916940 | 0.81 | LMNA (0.33) | LMNA | |
| SCHEMBL25917223 | 0.81 | LMNA (0.33) | LMNA | |
| SCHEMBL25860030 | 0.81 | LMNA (0.35) | LMNA | |
| SCHEMBL10179875 | 0.80 | LMNA (0.37) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130022669-A1 | BRANCHED, COMPACT POLYETHYLENEGLYCOL DERIVATIVES | SPAGO IMAGING AB (SE) | 2013-01-24 | — | — | US | disclosed |
| US-20130022669-A1 | BRANCHED, COMPACT POLYETHYLENEGLYCOL DERIVATIVES | SPAGO IMAGING AB (SE) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130022669-A1 | BRANCHED, COMPACT POLYETHYLENEGLYCOL DERIVATIVES | ALG1, OGT, KRTCAP2 | LMNA 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.